Skip to content

Frontlight ResearchEarly access

Trial site

Investigator site 20 - PL0480018

Lublin, 20-093, PolandEU-13 widening countryNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Myasthenia gravis

Closed trials

Completed
Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis
NCT04818671· Phase 3· argenx· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Investigator site 20 - PL0480018: trial site – Frontlight Research